Patients without cancer: Clinical characteristics according to long-term anticoagulant therapy.

<p><b><i>Abbreviations</i>:</b> VKA, vitamin K antagonists; LMWH, low-molecular-weight heparin; SD, standard deviation; CrCl, creatinine clearance; VTE, venous thromboembolism; DVT, deep vein thrombosis. Differences between patients starting VKA within the first week and the other groups</p><p>* p <0.05</p><p>^‡p <0.001.</p><p>Patients without cancer: Clinical characteristics according to long-term anticoagulant therapy.</p

Cancer patients: Clinical characteristics according to long-term anticoagulant therapy.

<p><b><i>Abbreviations</i>:</b> VKA, vitamin K antagonists; LMWH, low-molecular-weight heparin; SD, standard deviation; CrCl, creatinine clearance; VTE, venous thromboembolism; DVT, deep vein thrombosis. Differences between patients staring VKA within the first week and the other groups</p><p>* p <0.05</p><p>^†p <0.01</p><p>^‡p <0.001.</p><p>Cancer patients: Clinical characteristics according to long-term anticoagulant therapy.</p

Prescription of long-term therapy within the first 90 days in non-cancer patients.

<p>Prescription of long-term therapy within the first 90 days in non-cancer patients.</p

Prescription of long-term therapy within the first 90 days in patients with cancer.

<p>Prescription of long-term therapy within the first 90 days in patients with cancer.</p

Variables at baseline independently correlated to poor adherence to guidelines (VKA start <7 days for patients without cancer, and LMWH alone for patients with cancer).

<p><b><i>Abbreviations</i>:</b> OR, odds ratio; CI, confidence intervals; CrCl, creatinine clearance; VTE, venous thromboembolism; DVT, deep vein thrombosis.</p><p>Variables at baseline independently correlated to poor adherence to guidelines (VKA start <7 days for patients without cancer, and LMWH alone for patients with cancer).</p

Patients without cancer: country and long-term anticoagulant therapy.

<p>Patients without cancer: country and long-term anticoagulant therapy.</p

Patients with cancer: country and long-term anticoagulant therapy.

<p>Patients with cancer: country and long-term anticoagulant therapy.</p